The World Health Organization (WHO) is currently facing a significant budget shortfall of approximately $1.7 billion for its 2026 fiscal year. In response to this financial strain, which stems in part from the United States’ withdrawal during President Donald Trump’s administration, the organization has initiated a series of cost-cutting measures. These include reducing senior-level staff positions, freezing recruitment, and minimizing its global presence. Notably, the number of Assistant Directors-General has been halved from 12 to 6, and the number of department directors at the Geneva headquarters has been cut from over 70 to 36.
Despite these austerity measures, internal budget cuts are insufficient to resolve the WHO’s ongoing funding crisis. As a result, the organization may need to increasingly turn to private and corporate donors to bridge the financial gap. However, this shift raises concerns about the influence of non-state actors whose political or commercial agendas may not align with the WHO’s foundational mission—to promote the highest attainable standard of health for all people. Experts caution that greater dependence on private funding could risk allowing global health priorities to be shaped by the interests of a limited few rather than the broader public good.
